1. Home
  2. MDWD vs SHIP Comparison

MDWD vs SHIP Comparison

Compare MDWD & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • SHIP
  • Stock Information
  • Founded
  • MDWD 2000
  • SHIP 2008
  • Country
  • MDWD Israel
  • SHIP Greece
  • Employees
  • MDWD N/A
  • SHIP N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • SHIP Marine Transportation
  • Sector
  • MDWD Health Care
  • SHIP Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • SHIP Nasdaq
  • Market Cap
  • MDWD 195.2M
  • SHIP 183.3M
  • IPO Year
  • MDWD 2014
  • SHIP 2007
  • Fundamental
  • Price
  • MDWD $19.47
  • SHIP $8.07
  • Analyst Decision
  • MDWD Strong Buy
  • SHIP Strong Buy
  • Analyst Count
  • MDWD 2
  • SHIP 1
  • Target Price
  • MDWD $35.00
  • SHIP $11.00
  • AVG Volume (30 Days)
  • MDWD 83.0K
  • SHIP 149.9K
  • Earning Date
  • MDWD 11-25-2025
  • SHIP 11-04-2025
  • Dividend Yield
  • MDWD N/A
  • SHIP 9.44%
  • EPS Growth
  • MDWD N/A
  • SHIP N/A
  • EPS
  • MDWD N/A
  • SHIP 0.73
  • Revenue
  • MDWD $19,858,000.00
  • SHIP $147,718,000.00
  • Revenue This Year
  • MDWD $21.39
  • SHIP N/A
  • Revenue Next Year
  • MDWD $23.01
  • SHIP $14.29
  • P/E Ratio
  • MDWD N/A
  • SHIP $11.05
  • Revenue Growth
  • MDWD N/A
  • SHIP 1.66
  • 52 Week Low
  • MDWD $14.14
  • SHIP $4.78
  • 52 Week High
  • MDWD $22.51
  • SHIP $10.83
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 66.30
  • SHIP 46.27
  • Support Level
  • MDWD $17.72
  • SHIP $7.86
  • Resistance Level
  • MDWD $18.54
  • SHIP $8.18
  • Average True Range (ATR)
  • MDWD 0.62
  • SHIP 0.27
  • MACD
  • MDWD 0.22
  • SHIP -0.07
  • Stochastic Oscillator
  • MDWD 86.01
  • SHIP 41.41

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Geniuship, Premiership, Squireship, And Friendship.

Share on Social Networks: